Cassava Sciences' Alzheimer's drug simufilam failed key trial endpoints, leading to a stock plunge. See why SAVA stock is at risk of delisting or merger.
The Small Business Forum is the City’s signature in-person event designed to support business owners and entrepreneurs. The 2024 event has concluded, however supports for the Toronto business ...
We’re redefining business in our own way, on our own coastline. Where peace meets profit and ethics meets enterprise. Where students come together to create a more equitable and prosperous world for ...